Are you Dr. Samghabadi?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 14 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Lane BLVD L235
Palo Alto, CA 94305Phone+1 650-725-8383
Summary
- Dr. Peyman Samghabadi, MD is a board certified pathologist in Palo Alto, California. He is currently licensed to practice medicine in California. He is affiliated with UCSF Medical Center and Community Regional Medical Center.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Pathology-Anatomic and Clinical, 2013 - 2017
Stony Brook University Health Sciences Center School of MedicineClass of 2013
Certifications & Licensure
CA State Medical License 2014 - 2026- American Board of Pathology Pathology - Anatomic
- American Board of Pathology Cytopathology
- American Board of Pathology Neuropathology
Publications & Presentations
PubMed
- 5 citationsTBL1XR1 Mutations in Primary Marginal Zone Lymphomas of Ocular Adnexa are Associated with Unique Morphometric Phenotypes.Diwash Jangam, Kaushik Sridhar, Alexandra Butzmann, Peyman Samghabadi, Edward D. Plowey
Current Eye Research. 2020-06-19 - 2 citationsCorrection: Casein kinase 2 inhibition sensitizes medulloblastoma to temozolomide.Ryan T. Nitta, Sara Bolin, Emily Luo, David E. Solow-Cordero, Peyman Samghabadi
Oncogene. 2020-02-01 - 18 citationsCasein kinase 2 inhibition sensitizes medulloblastoma to temozolomideRyan T. Nitta, Sara Bolin, Emily Luo, David E. Solow-Codero, Peyman Samghabadi
Oncogene. 2019-08-12
